Concord Medical Services Holdings LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NYSE
Concord Medical Services Holdings Limited announced a significant adjustment to its ADS ratio, changing from one ADS representing three Class A ordinary shares to one ADS representing 30 Class A ordinary shares, effective July 30, 2024.
NYSE
20-F: Concord Medical Services Holdings Limited Files 20-F Report for Fiscal Year Ended December 31, 2024
Concord Medical Services Holdings Limited reports its financial results and operational activities for the fiscal year ended December 31, 2024, highlighting challenges and strategic initiatives.
NYSE
Concord Medical's 20-F filing highlights ongoing efforts to navigate PRC regulations, address financial losses, and maintain its NYSE listing amid PCAOB inspection uncertainties.